Extra相关文献与解析，生知库 | 链接生命科学的每一步

日期影响因子

Prospective high-throughput genome profiling of advanced cancers: results of the PERMED-01 clinical trial

晚期癌症的前瞻性高通量基因组分析：PERMED-01 临床试验结果

期刊:Genome Medicine

影响因子:11.2

doi:10.1186/s13073-021-00897-9

Bertucci, François; Gonçalves, Anthony; Guille, Arnaud; Adelaïde, José; Garnier, Séverine; Carbuccia, Nadine; Billon, Emilien; Finetti, Pascal; Sfumato, Patrick; Monneur, Audrey; Pécheux, Christophe; Khran, Martin; Brunelle, Serge; Mescam, Lenaïg; Thomassin-Piana, Jeanne; Poizat, Flora; Charafe-Jauffret, Emmanuelle; Turrini, Olivier; Lambaudie, Eric; Provansal, Magali; Extra, Jean-Marc; Madroszyk, Anne; Gilabert, Marine; Sabatier, Renaud; Vicier, Cécile; Mamessier, Emilie; Chabannon, Christian; Pakradouni, Jihane; Viens, Patrice; André, Fabrice; Gravis, Gwenaelle; Popovici, Cornel; Birnbaum, Daniel; Chaffanet, Max

发表日期：2021

文献求助收藏

Circulating Tumor Cells and Bevacizumab Pharmacokinetics during Neoadjuvant Treatment Combining Chemotherapy and Bevacizumab for Early Breast Cancer: Ancillary Analysis of the AVASTEM Trial

早期乳腺癌新辅助治疗期间化疗联合贝伐单抗治疗中循环肿瘤细胞和贝伐单抗药代动力学：AVASTEM试验的辅助分析

影响因子:4.4

doi:10.3390/cancers13010140

Sabatier, Renaud; Pierga, Jean-Yves; Curé, Hervé; Abulnaja, Rakan; Lambaudie, Eric; Bidard, François-Clément; Extra, Jean-Marc; Sfumato, Patrick; Gonçalves, Anthony

细胞生物学

发表日期：2021

文献求助收藏

Safety Results and Analysis of Eribulin Efficacy according to Previous Microtubules-Inhibitors Sensitivity in the French Prospective Expanded Access Program for Heavily Pre-treated Metastatic Breast Cancer

法国前瞻性扩大用药计划中，根据既往微管抑制剂敏感性对艾立布林疗效进行安全性结果和分析，该计划针对的是既往接受过大量预治疗的转移性乳腺癌患者。

期刊:Cancer Research and Treatment

影响因子:3.8

doi:10.4143/crt.2017.446

Sabatier, Renaud; Diéras, Véronique; Pivot, Xavier; Brain, Etienne; Roché, Henri; Extra, Jean-Marc; Monneur, Audrey; Provansal, Magali; Tarpin, Carole; Bertucci, François; Viens, Patrice; Zemmour, Christophe; Gonçalves, Anthony

发表日期：2018

文献求助收藏

Similar response profile to neoadjuvant chemotherapy, but different survival, in inflammatory versus locally advanced breast cancers

炎性乳腺癌与局部晚期乳腺癌对新辅助化疗的反应相似，但生存期不同。

期刊:Oncotarget

doi:10.18632/oncotarget.19732

Monneur, Audrey; Goncalves, Anthony; Gilabert, Marine; Finetti, Pascal; Tarpin, Carole; Zemmour, Christophe; Extra, Jean-Marc; Tallet, Agnès; Lambaudie, Eric; Jacquemier, Jocelyne; Houvenaeghel, Gilles; Boher, Jean-Marie; Viens, Patrice; Bertucci, François

发表日期：2017

文献求助收藏

Insights into Lysine Deacetylation of Natively Folded Substrate Proteins by Sirtuins

深入了解 Sirtuins 对天然折叠底物蛋白的赖氨酸脱乙酰化作用

期刊:Journal of Biological Chemistry

doi:10.1074/jbc.M116.726307

Philipp Knyphausen, Susanne de Boor, Nora Kuhlmann, Lukas Scislowski, Antje Extra, Linda Baldus, Magdalena Schacherl, Ulrich Baumann, Ines Neundorf, Michael Lammers

发表日期：2016

文献求助收藏

Prognostic impact of hormone receptor- and HER2-defined subtypes in inflammatory breast cancer treated with high-dose chemotherapy: a retrospective study

激素受体和HER2定义的亚型对接受大剂量化疗的炎性乳腺癌预后的影响：一项回顾性研究

期刊:Journal of Cancer

影响因子:3.2

doi:10.7150/jca.15797

Boudin, Laurys; Gonçalves, Anthony; Sfumato, Patrick; Sabatier, Renaud; Bertucci, François; Tarpin, Carole; Provansal, Magali; Houvenaeghel, Gilles; Lambaudie, Eric; Tallet, Agnes; Resbeut, Michel; Charafe-Jauffret, Emmanuelle; Calmels, Boris; Lemarie, Claude; Boher, Jean-Marie; Extra, Jean-Marc; Viens, Patrice; Chabannon, Christian

免疫/内分泌

发表日期：2016

文献求助收藏

Immunohistochemical subtypes predict the clinical outcome in high-risk node-negative breast cancer patients treated with adjuvant FEC regimen: results of a single-center retrospective study

免疫组织化学亚型可预测接受辅助FEC方案治疗的高危淋巴结阴性乳腺癌患者的临床结局：一项单中心回顾性研究的结果

期刊:BMC Cancer

影响因子:3.4

doi:10.1186/s12885-015-1746-3

Rahal, S; Boher, J M; Extra, J M; Tarpin, C; Charafe-Jauffret, E; Lambaudie, E; Sabatier, R; Thomassin-Piana, J; Tallet, A; Resbeut, M; Houvenaeghel, G; Laborde, L; Bertucci, F; Viens, P; Gonçalves, A

免疫/内分泌

发表日期：2015

文献求助收藏

Long-term survival of advanced triple-negative breast cancers with a dose-intense cyclophosphamide/anthracycline neoadjuvant regimen

采用高剂量环磷酰胺/蒽环类新辅助方案治疗晚期三阴性乳腺癌的长期生存率

期刊:British Journal of Cancer

影响因子:6.8

doi:10.1038/bjc.2014.81

Giacchetti, S; Porcher, R; Lehmann-Che, J; Hamy, A-S; de Roquancourt, A; Cuvier, C; Cottu, P-H; Bertheau, P; Albiter, M; Bouhidel, F; Coussy, F; Extra, J-M; Marty, M; de Thé, H; Espié, M

发表日期：2014

文献求助收藏

Are there candidates for high-dose chemotherapy in ovarian carcinoma?

卵巢癌患者中是否有适合接受大剂量化疗的？

期刊:Journal of Experimental & Clinical Cancer Research

影响因子:12.8

doi:10.1186/1756-9966-31-87

Sabatier, Renaud; Gonçalves, Anthony; Bertucci, François; Capiello, Maria-Antonietta; Rousseau, Frédérique; Lambaudie, Eric; Chabannon, Christian; Viens, Patrice; Extra, Jean-Marc

发表日期：2012

文献求助收藏

Aldehyde dehydrogenase 1-positive cancer stem cells mediate metastasis and poor clinical outcome in inflammatory breast cancer

醛脱氢酶 1 阳性癌症干细胞介导炎性乳腺癌的转移和不良临床结果

期刊:Clinical Cancer Research

影响因子:10

doi:10.1158/1078-0432.CCR-09-1630

Emmanuelle Charafe-Jauffret, Christophe Ginestier, Flora Iovino, Carole Tarpin, Mark Diebel, Benjamin Esterni, Gilles Houvenaeghel, Jean-Marc Extra, François Bertucci, Jocelyne Jacquemier, Luc Xerri, Gabriela Dontu, Giorgio Stassi, Yi Xiao, Sanford H Barsky, Daniel Birnbaum, Patrice Viens, Max S Wic

发育与干细胞

发表日期：2010

文献求助收藏